564 Results (Page 22 of 23)
Japan Markets Research Reports
Japan Biobanks Market Analysis
The Japan Biobanks Market was valued at $4,770.05 Mn in 2023 and is predicted to grow at a CAGR of 9.30% from 2023 to 2030, to $8,889.24 Mn by 2030. The key drivers of this industry include government support, increasing demand for biomedical research, and a high prevalence of diseases. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Japan Chronic Cough Therapeutics Market Analysis
Japan Chronic Cough Therapeutics Market was valued at $392 Mn in 2022 and is estimated to reach $758 Mn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the prevalent occurrence of chronic respiratory infections, often identified by persistent coughing. Leading participants in this market presently include Eisai Co., Taisho Pharmaceutical Co., Shionogi & Co., Daiichi Sankyo Co., Sumitomo Dainippon Pharma Co., AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis and GlaxoSmithKline.
Japan MRI Market Analysis
The Japan MRI Market was valued at $412.73 Mn in 2023 and is predicted to grow at a CAGR of 7% from 2023 to 2030, to $662.76 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, affordability, and growing government expenditure. The key players in the industry are Siemens Healthineers, GE Healthcare, Elekta AB, and Koninklijke Philips NV among others.
Japan Hypersomnia Therapeutics Market Analysis
The Japan Hypersomnia Therapeutics Market was valued at $63.25 Mn in 2023 and is predicted to grow at a CAGR of 3.5% from 2023 to 2030, to $80.47 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Aculys Pharma Inc., Teva, Takeda, and Eisai among others.
Japan Dental Implant Market Analysis
Japan Dental Implant Market was valued at $310.20 Mn in 2023 and is predicted to grow at a CAGR of 10.3% from 2023 to 2030, to $616.10 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, an aging population, advanced dental technology, and high dental awareness. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Japan Conjunctivitis Therapeutics Market Analysis
The Japan Conjunctivitis Therapeutics Market was valued at $255 Mn in 2022 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $403 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, technological advancements in the industry, and growing consumer demand for effective treatments. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Roche, Novartis, Santen, and Johnson & Johnson among others.
Japan Head and Neck Cancer Therapeutics Market Analysis
The Japan Head and Neck Cancer Therapeutics Market was valued at $33.55 Mn in 2023 and is predicted to grow at a CAGR of 11.50% from 2023 to 2030, to $71.88 Mn by 2030. The key drivers of this industry include the aging population, advanced healthcare system, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Pfizer and AstraZeneca among others.
Japan PET Scan Market Analysis
The Japan PET Scan Market was valued at $120.6 Mn in 2023 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $180.1 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the Japan PET Scan Market are GE Healthcare, Siemens Healthineers, Terumo, Toshiba, Schiller, and Hitachi, among others.
Japan Genomic Diagnostics Market Analysis
Japan Genomic Diagnostics Market was valued at $2,029.48 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $6,090.96 Mn by 2030. The key drivers of this industry include an aging population, rising healthcare expenditure, and technological advancements. The industry is primarily dominated by Illumina, 23andMe, Sysmex Corporation, Fujitsu Laboratories among others.
Japan Compression Therapy Market Analysis
Japan Compression Therapy Market was valued at $236 Mn in 2022 and is estimated to reach $379 Mn in 2030, exhibiting a CAGR of 6.1% during the forecast period. The increasing occurrence of venous disorders such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Major participants in this sector include companies like Mölnlycke Health Care AB, Sigvaris, GC Medical Supply Co., Medi, Bauerfeind, Juzo, McKesson Corporation, Cardinal Health, BSN Medical, and Hartmann Group.
Japan Bio-implant Market Analysis
The Japan Bio-implant Market was valued at $4040.3 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $6237.4 Mn by 2030. The Japan Bio-implant Market is growing due to Aging Population, Increasing Awareness and Acceptance, and Chronic Disease Prevalence. The market is primarily dominated by players such as Terumo Corporation, Nipro Corporation, Olympus Corporation, Japan Medical Dynamic Marketing, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc.
Japan Mouth Ulcer Therapeutics Market Analysis
The Japan Mouth Ulcer Therapeutics Market was valued at $94.5 Mn in 2023 and is projected to grow at a CAGR of 4.4% from 2023 to 2023, to $127.7 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Otsuku Pharmaceuticals, Eisai, Daiichi Sankyo, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Pfizer, Inc. among others.
Japan Exosome Research Market Analysis
The Japan Exosome Research Market was valued at $10.5 Mn in 2023 and is projected to grow at a CAGR of 16.5% from 2023 to 2023, to $30.6 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as CRAIF, Toyobo, Kangstem Biotech, Digzyme, Thermo Fisher Scientific among others.
Japan Bariatric Surgery Devices Market Analysis
The Japan Bariatric Surgery Devices Marketwas valued at $165.3 Mn in 2023 and is projected to grow at a CAGR of 5.7% from 2023 to 2023, to $243.7 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Medtronic, B. Braun, Olympus Corporation among others.
Japan CT Scan Market Analysis
Japan CT Scan Market was valued at $286.55 Mn in 2023 and is predicted to grow at a CAGR of 8.37% from 2023 to 2030, to $503 Mn by 2030. The key drivers of this industry include the aging population, rising chronic disease burden, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Japan Lipid Disorder Therapeutics Market Analysis
The Japan Lipid Disorder Therapeutics Market was valued at $277.8 Mn in 2023 and is predicted to grow at a CAGR of 11.63% from 2023 to 2030, to $600 Mn by 2030. Japan Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Cardiovascular Disease, Growing Awareness, and Government Initiatives, and Technological Advancements. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd.Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Japan Castrate Resistant Prostate Cancer Therapeutics Market Analysis
Japan Castrate Resistant Prostate Cancer Therapeutics Market valued at $634 Mn in 2022, projected to reach $1139 Mn by 2030 with a 7.6% CAGR. The key driver of the market in Japan is the significant surge in the aging population, particularly those at higher risk of age-related cancers, coupled with increased diagnostics, screening, and a growing awareness of the disease and treatment options. The Japan Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Sanofi, Bayer, Astellas, AbbVie, Eisai, Novartis, AstraZeneca, Bristol-Myers Squibb, etc, among various others.
Japan Constipation Therapeutics Market Analysis
Japan Constipation Therapeutics Market was valued at $1131 Mn in 2022 and is estimated to reach $1944 Mn in 2030, exhibiting a CAGR of 7% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Roche, and Sanofi.
Japan Herbal Supplements Market Report
The Japan Herbal Supplements Market was valued at $326.95 Mn in 2023 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $514.80 Mn by 2030. The key drivers of this industry include an aging population, preventive healthcare, and cultural orientation. The industry is primarily dominated by players such as Tsumura & Co, Eisai Co., Ltd, Herbalife, and NOW Foods among others.
Japan Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Japan Clinical Nutrition for Chronic Kidney Diseases Market was valued at $97.60 Mn in 2023 and is predicted to grow at a CAGR of 6.53% from 2023 to 2030, to $151.90 Mn by 2030. The key drivers of this industry include the high prevalence of CKD, increasing awareness and education, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Japan Brugada Syndrome Market Analysis
The Japan Brugada Syndrome Market was valued at $74.6 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $130.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the Japan Brugada Syndrome Market are Takeda Pharmaceuticals, Astellas, Canon Medical Systems Corporation, Terumo, Nipro, and Otsuka, among others.
Japan Blood Disorder Therapeutics Market
Japan Blood Disorder Therapeutics Market valued at $833 Mn in 2022, projected to reach $1,542 Mn by 2030 with a 8% CAGR. The key drivers of market growth include the higher prevalence of hemophilia A, improved awareness and diagnoses, growing adoption of advanced therapies, and government efforts to support the pharmaceutical industry. The Japan Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, Roche, Bayer, Novartis, KM Pharmaceuticals, Chugai Pharmaceuticals, Eisai, Kyowa Kirin, Daiichi Sankyo, etc, among various others.
Japan Dental Endodontics Market Analysis
Japan Dental Endodontics Market was valued at $108.80 Mn in 2023 and is predicted to grow at a CAGR of 4.8% from 2023 to 2030, to $151 Mn by 2030. The key drivers of this industry include a focus on oral health, the aging population, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Japan Clinical Nutrition Market Analysis
The Japan Clinical Nutrition Market was valued at $1906.4 Mn in 2023 and is projected to grow at a CAGR of 5.84% from 2023 to 2023, to $2836.4 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto, Abbott Nutrition, Nestle, Mead Johnson & Company, LLC among others.
Japan Breast Pump Market Report
The Japan Breast Pump Market was valued at $182.8 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $336.2 Mn by 2030. The key drivers of the market include increasing female workforce participation, government support, and technological advancements. The prominent players in the Japan Breast Pump Market are Horigen, Pigeon, Asia Connection, Philips Avent, Ardo Medical AG, Youha, and Magneto, among others.
